SKYSTAR BIO-PHARMACEUTICAL REPORTS RECORD REVENUE AND INCOME

Skystar Bio-Pharmaceutical, a leading Bio-Pharmaceutical Company in China, announced record financial results for the year ended December 31, 2005. Skystar reported a 48.6% increase in total revenue for 2005. Total revenue for 2005 grew to $5,939,416 as compared with the year-earlier period's revenue of $3,996,421.

MarketWire (http://www.marketwire.com/mw/release_html_b1?release_id=125264)